ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VRPX Virpax Pharmaceuticals Inc

0.6767
-0.0507 (-6.97%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Virpax Pharmaceuticals Inc VRPX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0507 -6.97% 0.6767 09:00:00
始値 安値 高値 終値 前日終値
0.73 0.649 0.73 0.70 0.7274
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2920:30BWVirpax® Pharmaceuticals to Present at 2024 BIO International..
2024/5/1805:05EDGAR2Form 8-K - Current report
2024/5/1705:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/5/1521:00BWVirpax Announces Pricing of $2.25 Million Public Offering
2024/5/1513:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/5/1406:30EDGAR2Form S-1/A - General form for registration of securities..
2024/5/1405:20EDGAR2Form 8-K - Current report
2024/5/1405:10BWVirpax Pharmaceuticals Reports 2024 First Quarter Results..
2024/5/1405:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/4/3020:30BWVirpax Announces Results of Maximum Tolerated Dose Study for..
2024/3/2620:30BWVirpax Pharmaceuticals Reports 2023 Year-End Results
2024/2/2721:31BWVirpax Pharmaceuticals Announces Reverse Stock Split to..
2024/2/2721:30BWVirpax Pharmaceuticals Announces Proposed Settlement of..
2024/2/0721:30BWVirpax Pharmaceuticals Announces Preliminary Results of..
2024/2/0106:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2921:30EDGAR2Form 8-K - Current report
2023/12/2921:30BWVirpax Pharmaceuticals Announces Results of Special..
2023/12/1322:30EDGAR2Form 8-K - Current report
2023/12/0723:08EDGAR2Form DEF 14A - Other definitive proxy statements
2023/12/0722:58EDGAR2Form 8-K - Current report
2023/12/0722:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/2206:57EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/1721:30EDGAR2Form 8-K - Current report
2023/11/1721:15EDGAR2Form 8-K - Current report
2023/11/1721:10BWVirpax Pharmaceuticals Announces Notification from Nasdaq..
2023/11/1721:00BW Virpax Pharmaceuticals Announces Leadership Transition
2023/11/1706:51EDGAR2Form 8-K - Current report
2023/11/1606:15BWVirpax Pharmaceuticals Reports 2023 Third Quarter Results..
2023/11/1605:03EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2023/10/3121:58BWVirpax Pharmaceuticals Announces that Envelta™ Remains on..
2023/10/1221:02BWVirpax Pharmaceuticals Announces Extension of CRADA with the..
2023/10/1205:10EDGAR2Form 8-K - Current report
2023/10/0322:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0221:58BWGerald W. Bruce Appointed President and CEO of Novvae™..
2023/9/2721:58BWVirpax Pharmaceuticals Announces Results of Probudur™ Dose..
2023/9/2621:58BWVirpax Pharmaceuticals to Present at the LD Micro Main Event..
2023/9/2202:35BWAltasciences von Virpax ausgewählt, um die Entwicklung eines..
2023/9/2202:18BWAltasciences choisi par Virpax pour soutenir le..
2023/9/2123:00BWAltasciences Chosen by Virpax to Support the Development of..
2023/9/1820:58BWVirpax Pharmaceuticals Announces the Formation of Novvae™..
2023/9/0522:28EDGAR2Form 8-K - Current report
2023/9/0522:00BWVirpax Pharmaceuticals Updates on Litigation
2023/8/2821:58BWVirpax® Pharmaceuticals to Present at H.C. Wainwright 25th..

最近閲覧した銘柄

Delayed Upgrade Clock